Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2902
Selected: 0
NCT IDTitle
NCT03215927Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
NCT05838781DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation
NCT06086886A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
NCT00435669A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
NCT06869551A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
NCT00420186A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
NCT00208169Abilify Therapy for Reducing Comorbid Substance Abuse
NCT01194856Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
NCT01002807Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State
NCT03873402A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
NCT02413372A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
NCT00050102Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
NCT02034591Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects
NCT07024862Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy
NCT04688658Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
NCT00971308Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus
NCT02017717A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
NCT01088360Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
NCT02705989Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects
NCT03981146A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT00017043BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
NCT04635735Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
NCT05034926A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus
NCT05200143Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
NCT01409174IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
NCT03378310A Study in Healthy Participants Evaluating the Absorption of a BMS-986205 Tablet Into the Bloodstream Compared to a Reference Tablet
NCT05567458A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
NCT03040791Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)
NCT04787991Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
NCT00826449Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
NCT04966663Using ctDNA to Determine Therapies for Lung Cancer
NCT04941755A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
NCT04095208Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
NCT00481325Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
NCT00277199Comparability DE vs CD-CHO1
NCT03995017Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma
NCT02169544Post-marketing Study Assessing the Long-Term Safety of Abatacept
NCT01305538Crossover Post-herpetic Neuralgia (PHN)
NCT02542852A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia
NCT00546247A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)
NCT03271047Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
NCT03891108A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants
NCT04328298French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
NCT02534506Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors
NCT03544736Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
NCT02161406A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
NCT02976493Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma
NCT05599685A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
NCT07225647A Study to Assess the Effect of Food on the Drug Levels of Admilparant